COVID-19 Acceleration and Vaccine Status in France – August 2021 ( Unvaccinated and Vaccinated Similar since July 2021)

Read Time:2 Minute, 7 Second

Quote: (Full Study) : “The fact that acceleration persists even among the vaccinated population is broadly consistent with recent biological evidence that vaccinated and unvaccinated individuals have similar viral loads where the SARS-CoV-2 delta variant is most prevalent and that vaccine breakthroughs are seen more often in comparison with previous variant”

Abstract

Abstract: Objectives: This note provides an assessment of COVID-19 acceleration among groups with difference vaccine status in France. Methods: We assess viral acceleration using a novel indicator introduced in Baunez et al. (2021). The acceleration index relates the percentage change of tests that have been performed on a given day to the percentage change in the associated positive cases that same day. We compare viral acceleration among vaccinated and unvaccinated individuals in France over the period May 31st – August 29, 2021. Results: Once the state of the epidemic within each groups is accounted for, it turns out that viral acceleration has since mid-July converged to similar levels among vaccinated and unvaccinated individuals in France, even though viral speed is larger for the latter group compared to the former. Conclusion: Our results call for an increasing testing effort for both vaccinated and unvaccinated individuals, in view of the fact that viral circulation is currently accelerating at similar levels for both groups in France.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors received no specific funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv



Categories: All Posts

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
%d bloggers like this: